If there is any information that you would like included on this page please contact Alexandra Fullem (alexfullem@gmail.com). The website is updated approximately twice a month.
PDP Press Releases/ statements
• 10 Jul: IAVI receives €1 million from Dutch government for Sudan virus vaccine development
• 12 May: Strengthening regional R&D: Integrated Dengue control in urban Malaysia
• 23 Apr: Afrigen Biologics and Vaccines: A Catalyst in mRNA Technology and LMIC Capacity Strengthening
• 24 Apr: Price of Key DR-TB Medicine Drops 25% as TB Alliance’s Multi-Manufacturer Strategy Expands Access
• 17 Jun: New global collaboration launched to tackle antimicrobial resistance through improved diagnostics
• 26 Jun: Dapivirine vaginal ring recommended as an HIV prevention option for adolescent girls
• 27 Jun: A shot of hope: How the malaria vaccine is helping to change lives in Kenya
• 8 Jul: First malaria medicine for newborn babies and young infants <4.5 kg receives approval
• 10 Jun: MMV’s scientific advisor appointed Director General of African Medicines Agency
• 16 Jul: MMV Annual Report 2024
• 27 Jun: MMV 2024 Annual Report
• 1 Jul: Thailand’s Government Pharmaceutical Organization (GPO) partners with DNDi and Pharco to register an effective and affordable hepatitis C treatment
• 5 Jun: Meet the DNDi Eastern Africa 2024-2025 Media Fellows
• 10 Jul: LEO Foundation partners with DNDi to develop breakthrough drug discovery model for mycetoma
• 10 Jul: New HIV project in the DRC brings life-saving care closer to people with advanced HIV disease
• 15 Jul: DNDi 2024 Annual Report
• 2 Jul: FIND Board Chair Dr Ayoade Alakija Appointed Ministerial Global Envoy for Antimicrobial Resistance
• 17 Jul: EVI launches new global collaboration to advance promising malaria vaccine candidate: SEmalvac6
• 14 Apr: EVI to support GAVI's malaria learning agenda
MDGH
• 20 Feb: U.S. FDA expands indication for moxidectin to treat river blindness in children as young as four
PDP Funder News/Announcements
• 2 Jul: Commission launches new strategy to make Europe a global leader in life sciences by 2030. European Commission
• 3 Jul: Global Health EDCTP3 and CEPI join forces to tackle epidemic threats. EDCTP
• 4 Jul: Unitaid launches new funding opportunity to support cost-effective and impactful rollout of lenacapavir in sub-Saharan Africa. Unitaid
• 7 Jul: 5 innovations to watch. Unitaid
• 15 Jul: Unitaid and partners announce new financing agreement with Synergy Gases Ltd to boost medical oxygen access in sub-Saharan Africa. Unitaid
• 17 Jul: Unitaid and PATH partner to ensure babies are born free of preventable disease through new community and country led initiative. Unitaid
• 24 Jun: Child Deaths Will Rise if Funding for Lifesaving Vaccine Program Falters. Gates Foundation
• 25 Jun: GHIT Annual Report 2024. GHIT
• 25 Jun: UK partners with Gavi to help save up to 8 million lives by 2030. UK Government
• 27 Jun: EDCTP Forum: from Kigali to Madrid. EDCTP
Funder Announcement Archives
• 2014 PDP Funder Announcements
• 2013 PDP Funder Announcements
New PDP Publications
• 25 Apr: Rethinking antibodies for infectious diseases?. IAVI
Other Reports/ Publications
• 12 May: Securing Britain’s Future: How Investments in Ending Malaria Strengthen the UK Economy, Life Sciences Sector and NHS. Malaria No More UK
Related Press Releases/ Announcements/Articles
• 1 Jul: Obama and Bush call Trump’s USAID closure a ‘travesty’ as report warns of 14 million extra deaths. The Guardian
• 1 Jul: EXCLUSIVE: WHO Chief Names New Team of Directors – Mostly Familiar Faces. Health Policy Watch
• 1 Jul: Targeting RAP proteins for next-generation malaria treatments. News Medical
• 1 Jul: Safety and immunogenicity of investigational tuberculosis vaccine M72/AS01E–4 in people living with HIV in South Africa: an observer-blinded, randomised, controlled, phase 2 trial. The Lancet HIV
• 1 Jul: USAID cuts could lead to 14 million deaths over the next five years, researchers say. NBC News
• 1 Jul: Insufficient testing allows Sierra Leone’s mpox outbreak to surge. Nature Africa
• 1 Jul: Six things you need to know about how vaccines fight antimicrobial resistance. Gavi
• 2 Jul: RFK Jr.’s intellectually dishonest excuse for defunding Gavi, the Vaccine Alliance. STAT
• 2 Jul: Can health survive the development finance revolution?. Devex
• 2 Jul: Gavi’s Sania Nishtar is ‘very hopeful’ US will return as a donor. Devex
• 2 Jul: U.S. Retreat From Global Vaccine May Increase Diseases, Experts Warn. Forbes
• 2 Jul: Partnership aims to foster development of drug for non-TB mycobacteria. CIDRAP
• 2 Jul: USAID Formally Shut Down – Days After Scientists Warn Closure Will Kill 2.4 Million People Every Year. Health Policy Watch
• 2 Jul: As mosquito season peaks, officials brace for new normal of dengue cases. News Medical
• 2 Jul: Antifungal discovery offers hope against deadly drug-resistant infections. MedicalXpress
• 2 Jul: Leadership change at African journal sparks calls for bold reform. Nature
• 2 Jul: Impact of PEPFAR Stop Work Orders on PrEP. AVAC
• 3 Jul: Undoing progress through sudden tuberculosis funding cuts. The Lancet
• 3 Jul: The investment shift that could reshape African health care. Devex
• 3 Jul: NIH restores grants to South Africa scientists, adds funding option for other halted foreign projects. Science
• 3 Jul: Inspired by bombardier beetle, Tulane team propels instrument-free latent tuberculosis test. 360Dx
• 3 Jul: The case for optimal investment in combating HIV, tuberculosis, and malaria: a global modelling study. The Lancet
• 3 Jul: Pandemic speed: How rapid-response science saves lives. Gavi
• 3 Jun: New mRNA vaccine is more effective and less costly to develop, study finds. MedicalXpress
• 3 Jul: Mpox cases decline in Sierra Leone as Africa faces shortage in vaccine funding. CIDRAP
• 3 Jun: Substandard and falsified antibiotics are associated with antimicrobial resistance: a retrospective country-level analysis. BMJ
• 4 Jun: Trump Budget Eliminates Funding for Crucial Global Vaccination Programs. The New York Times
• 4 Jul: Study Validates Impact of International Teams in Africa’s Outbreak Response. Africa CDC
• 4 Jun: Trump budget request and rescission plan slashes global health funding. Devex
• 4 Jun: Current state and future directions of interventions for neglected tropical diseases. Nature
• 4 Jun: Cepheid HIV viral load test receives Health Canada license. 360Dx
• 5 Jun: Scientists devise plan to curb fatalities from deadly superbugs: 'One of the most pressing global health and development challenges of our time'. The Cool Down
• 5 Jun: Breakthrough in search for HIV cure leaves researchers ‘overwhelmed’. The Guardian
• 5 Jul: Wellcome CEO Urges Global Health Rethink: ‘Science Alone Is Not Enough’. Health Policy Watch
• 5 Jul: Mpox in DR Congo: a call to action. The Lancet
• 5 Jul: NIH restores grants to South Africa scientists, adds funding option for other halted foreign projects. European AIDS Treatment Group
• 5 Jul: Achieving equitable access to health technologies during a pandemic: Lessons learned from UK universities’ technology transfer practices & policies 2019–2023. Global Public Health
• 5 Jun: Reimagining Antimicrobial Resistance (AMR) financing for Africa amid global funding crises. PLOS
• 5 Jun: Antibodies Remain 6 Months After Chikungunya Vaccine Administered in Youngest Children. Contagion Live
• 6 Jun: Sierra Leone battles intense mpox activity as Ethiopia reports first death. CIDRAP
• 6 Jun: Analysis shows mpox lurked in Nigeria for 8 years before igniting global 2022 outbreak. CIDRAP
• 6 Jun: Role of malaria exposure and off-target responses on RTS,S/AS02A vaccine immunogenicity and protection in Mozambican children. Nature
• 6 Jun: WHO Releases Bibliography on Antimicrobial Resistance: A Vital Tool in a Global Health Battle. TWN
• 6 Jun: mRNA HIV vaccine shows promise in proof-of-concept clinical trials. Tides Global
• 6 Jun: Skyrocketing mpox outbreak in Sierra Leone raises fears of wider spread. Nature
• 7 Jul: Equitable Access Review of CEPI’s Chikungunya Partnership Agreements. O’Neill Institute
• 7 Jul: COVAX: The “world first” vaccine sharing scheme that saved millions. Gavi
• 7 Jul: Urgent health gaps targeted at UN financing summit, and other health stories. WEF
• 8 Jul: Novartis receives approval for first malaria medicine for newborn babies and young infants. BioSpace
• 8 Jul: First malaria treatment for babies approved for use. BBC
• 8 Jul: Tiny nanobody shows big promise in fighting Nipah and Hendra viruses. News Medical
• 8 Jul: It’s time to build a field for health commodity financing: Sustainable domestic systems to ensure access to essential medicines and products. R4D
• 8 Jul: The patient pursuit of safe treatment options for tuberculosis. The Lancet
• 8 Jul: Delpazolid in combination with bedaquiline, delamanid, and moxifloxacin for pulmonary tuberculosis (PanACEA-DECODE-01): a prospective, randomised, open-label, phase 2b, dose-finding trial. The Lancet
• 9 Jul: Despite RFK Jr’s hesitancy the HHS is quietly looking at developing two new vaccines. The Independent
• 9 Jul: Next Phase of Pandemic Talks Resumes, Tackling Tricky Issue of Sharing Pathogen Information. Health Policy Watch
• 9 Jul: Growing Role In Global Health Innovation: Nigeria Among Eight African Nations Set To Approve First Malaria Medicine For Newborns. Forbes Africa
• 9 Jul: Global Fund Secures Access to Breakthrough HIV Prevention Drug Lenacapavir for Low- and Middle-Income Countries. The Global Fund
• 9 Jul: NIH-funded Human Trials Outside US Get Temporary Funding Reprieve. Health Policy Watch
• 9 Jul: The economic burden of malaria in Africa: a systematic review of cost of illness studies. Malaria Journal
• 9 Jul: Why we should be redefining the private sector's role in global health. WEF
• 9 Jul: New compounds kill the parasite that causes Chagas disease in mice by disrupting protein synthesis. Fierce Biotech
• 9 Jul: New vaccine set for human trials in Nipah outbreak hotspot. CEPI
• 9 Jul: Gilead to provide HIV prevention drug to 2 million people in lower-income countries at cost. STAT
• 9 Jul: Understanding the political economy of reforming global health initiatives – insights from global and country levels. Globalisation & Health
• 9 Jul: First mRNA vaccine for Marburg shows promise in animal trial. The Telegraph
• 9 Jul: Mpox in Africa: funding cuts and delayed global actions fuelling new epicentres. The Lancet
• 10 Jul: Global cost of silencing science: editors and publishers have a duty to resist. The Lancet
• 10 Jul: Stop TB cuts over a quarter of staff amid shift in US priorities. Devex
• 10 Jul: Devex CheckUp: $1.4B Global Fund cuts hit over 100 countries. Devex
• 10 Jul: World Health Organization Advances Deep Staff Cuts – Unclear How Strategic Priorities Will be Reflected. Health Policy Watch
• 10 Jul: A 3D culture model facilitates mass production of in vitro Plasmodium falciparum haemolymph-like sporozoites. Malaria Journal
• 10 Jul: Millions at Risk of HIV Infection and Death After US Funding Cuts, Warns UNAIDS. Health Policy Watch
• 10 Jul: Academic groups finalize counterproposal to Trump’s research overhead cuts. STAT
• 10 Jul: Global cost of silencing science. BMJ
• 10 Jul: Now What with Injectable LEN for PrEP?. AVAC
• 10 Jul: Promising vaccine against deadly Nipah virus can also treat infection. Nature
• 10 Jul: Mpox cases rise in handful of Africa's outbreak countries. CIDRAP
• 10 Jul: In 2 trials, less toxic TB antibiotics show promise. CIDRAP
• 10 Jul: Trump seeks to cut basic scientific research by roughly one-third, report shows. The New York Times
• 10 Jul: Unmet needs in vaccine development. Nature
• 10 Jul: Global progress on neglected tropical diseases. The Lancet Infectious Diseases
• 11 Jul: Lessons for long-acting lenacapavir: catalysing equitable PrEP access in low-income and middle-income countries. The Lancet HIV
• 11 Jul: Daring to dream of long-acting HIV prevention. The Lancet HIV
• 11 Jul: Improving access to innovative medicines in Africa starts with clinical trials. Gavi
• 11 Jul: Sustainable development programmes key to tackling antimicrobial resistance. LSTMH
• 11 Jul: New Body Adopts Intense Timetable for Final Pandemic Agreement Talks. Health Policy Watch
• 11 Jul: Exclusive: NIH suspends dozens of pathogen studies over ‘gain-of-function’ concerns. Science
• 12 Jun: Gavi and Asian Development Bank sign new partnership to boost health financing for immunisation. Gavi
• 12 Jul: ‘We will go on’: Global health nonprofit PATH navigates U.S. funding freeze from new Seattle HQ. Geek Wire
• 12 Jun: The Front Lines of Tuberculosis Vaccine Research. The Medicine Maker
• 12 Jun: Stop TB Partnership retains US funds but must revise scope, cut staff. Devex
• 12 Jun: USAID’s Role in Global Health Supply Chain Programs and Implications of Aid Cuts: A Rapid Review. CGD
• 12 Jun: Stop TB Partnership retains US funds but must revise scope, cut staff. Devex
• 13 Jun: Mpox Vaccine Manufacturer Urged to Drop Price Amid Huge Shortfall in Africa. Health Policy Watch
• 13 Jul: Emergency vaccine response cut infectious disease deaths by nearly 60% since 2000. MSN
• 13 Jul: US aid cuts halt HIV vaccine research in South Africa, with global impact. The Independent
• 13 Jun: How the malaria vaccine came to the world’s most mosquito-bitten district. Gavi
• 13 Jun: Congress shows first signs of resisting Trump’s plans to slash science budgets. Science
• 13 Jul: Exclusive: NIH to dismiss dozens of grant reviewers to align with Trump priorities. Nature
• 14 Jul: Bill Gates: U.S. Aid for Global Health Is Saving Lives. Wall Street Journal
• 14 Jul: Guidelines on lenacapavir for HIV prevention and testing strategies for long-acting injectable pre-exposure prophylaxis. WHO
• 14 Jul: WHO recommends injectable lenacapavir for HIV prevention. WHO
• 14 Jul: Gilead Presents New Data on Twice-Yearly Lenacapavir (Yeztugo®) for HIV Prevention at IAS 2025. Gilead
• 14 Jul: Merck to Initiate Phase 3 Trials for Investigational Once-Monthly HIV Prevention Pill. Merck
• 14 Jul: ViiV Healthcare Extends Voluntary Licensing Agreement with Medicines Patent Pool to Enable Access to Innovative Long-Acting Injectable HIV Treatment.ViiV Healthcare
• 14 Jul: The impact of sulfadoxine–pyrimethamine resistance on the effectiveness of intermittent preventive treatment for the prevention of malaria in pregnancy in Africa: an updated systematic review and meta-analysis. The Lancet Infectious Diseases
• 15 Jul: The importance of funding and investment to strengthen data science in Africa. Nature
• 15 Jul: A Different Angle on Malaria Control: Blocking Transmission from People to Mosquitoes. NEJM
• 15 Jul: New ADB platform aims to help end malaria, TB, and dengue in Asia-Pacific. Devex
• 16 Jul: PEPFAR Spared for Now – But US Spending on Global Health Programs Still Face Cuts. Health Policy Watch
• 16 Jul: Funding for lifesaving global health programs forecast to reach 15-year low. MedicalXpress
• 16 Jul: Senate blocks $400M cut to PEPFAR, but it's a shell of its former self. Devex
• 17 Jul: Could Antibody-Based Interventions Hold The Key To Tackling The World’s Deadliest Malaria Parasite (Also The Most Prevalent In Africa)?. Forbes Africa
• 17 Jul: The Pepfar programme keeps millions with HIV alive – a new push seeks to save it from Trump’s aid cuts. The Independent
• 17 Jul: Congress Agrees to Claw Back Foreign Aid and Public Broadcast Funds. The New York Times
• 17 Jul: Estimating investment needed to optimally combat HIV, TB, and malaria. Harvard T.H. Chan School of Public Health
• 17 Jul: Vaccination to mitigate climate-driven disruptions to malaria control in Madagascar. Science
• 17 Jul: US has wasted hundreds of thousands of vaccines meant for Africa, health officials there say. Politico
• 17 Jul: How the Senate saved PEPFAR — but still greenlit billions in aid cuts. Devex
• 17 Jul: US aid cuts overshadow HIV research advances. Devex
• 17 Jul: How Asia-Pacific can boost vaccine access in the next pandemic. Devex
• 17 Jul: Bridging the global gap in access to essential medicines. OCHR
• 17 Jul: HIV Research on Pause. AVAC
• 17 Jul: endTB-Q Study Shows Tailored Treatment is Important for Hard-to-Treat Tuberculosis. Partners in Health
• 18 Jul: RMRC Bhubaneswar develops advanced malaria vaccine, ready for tech transfer. The New Indian Express
• 19 Jun: Nigerian company to make HIV, malaria test kits after US funding cut. Reuters
• 19 Jun: New dual-adjuvant vaccine strategy offers hope in the fight against HIV. News Medical
• 19 Jun: Pioneering research to develop all-in-one vaccine against some of the world’s most deadly diseases. CEPI
• 20 Jul: The case for optimal investment in combating HIV, tuberculosis, and malaria: a global modelling study. The Lancet
• 20 Jun: New ways to tackle antimicrobial resistance. European Pharmaceutical Manufacturer
• 21 Jun: Estimating the potential malaria morbidity and mortality avertable by the US President's Malaria Initiative in 2025: a geospatial modelling analysis. The Lancet
• 21 Jun: Reinforcing resilience: confronting the consequences of global malaria aid cuts in Africa. The Lancet
• 21 Jun: Africa's role in the WHO Pandemic Agreement. The Lancet
• 21 Jun: The mpox response: African leadership, global responsibility. The Lancet
• 21 Jun: Trump aid cuts deal a blow to HIV prevention in Africa. Reuters
• 22 Jun: Here Is All the Science at Risk in Trump’s Clash With Harvard. The New York Times
• 23 Jun: Developing globally-accessible medicines for pandemic preparedness: An analysis of three alternative innovation models. Global Public Health
• 23 Jun: Japan has more than doubled its foreign aid budget in just five years. Our World in Data
• 23 Jun: Will Gates and other funders save massive public health database at risk from Trump cuts?. Nature
• 23 Jun: $9 Billion, 500 Million Children, $250 Billion ROI: Why Gavi's Brussels Summit Matters. Gavi
• 23 Jun: Opinion: If Gavi plans a ‘sunset,’ let it be a thoughtful transition. Devex
• 23 Jun: Malaria Vaccines Free Up Clinics to Improve Child Health in Cameroon. Medium
• 24 Jun: The Drug That Could Revolutionize the Fight Against H.I.V. The New Yorker
• 24 Jun: Norway Reaffirms Health Leadership with First Public Pledge to Global Fund’s 2025 Replenishment. The Global Fund
• 24 Jun: Malaria protein plays dual role in immune evasion and activation. News Medical
• 24 Jun: Gates Foundation to commit $1.6 billion for Gavi vaccine alliance. Reuters
• 24 Jun: Balancing promise and peril: risk management in India's BPaL introduction. The Lancet
• 24 Jun: Norway puts brakes on Gavi pledge, old promises strain the budget. Development Today
• 24 Jun: US scientific leadership faces uncertain future amid HHS overhaul. GHTC
• 24 Jun: Agile policies for antimicrobial resistance: A contextual approach to sustainable health challenges. Global Public Health
• 24 Jun: Blended Finance Won’t Save Global Health – Renewed Public Sector Commitment Might. Geneva Health Files
• 24 Jun: Can monoclonal antibodies effectively treat malaria? Scientists say the answer is a resounding 'yes'. MedicalXpress
• 24 Jun: Bill Gates says he will not fill vaccine funding gap left by aid cuts. Financial Times
• 24 Jun: The future of global health is innovation. Global Health Insights
• 24 Jun: Trinity Biotech nabs WHO approval for outsourced manufacturing of rapid HIV test. 360Dx
• 24 Jun: Antimicrobial resistance in Africa: A retrospective analysis of data from 14 countries, 2016–2019. PLOS Medicine
• 24 Jun: Financing Health Innovation in Africa. Think Global Health
• 25 Jun: Gavi Seeks Support Amid Global Vaccination Backsliding. Health Policy Watch
• 25 Jun: Germany pledges 600 million euros to vaccine group Gavi. Reuters
• 25 Jun: Opinion: 5 realities and 5 opportunities for global health financing. Devex
• 25 Jun: Price of world’s first malaria vaccine (RTS,S) for children in endemic countries to be reduced by more than half, to less than $5. GSK
• 25 Jun: Africa launches landmark consortium to transform health research with longitudinal data. Centre for Tropical Medicine and Global Health
• 25 Jun: RFK Jr. says US won’t donate to global vaccine effort. Politico
• 25 Jun: Promise of Victory Over H.I.V. Fades as U.S. Withdraws Support. The New York Times
• 25 Jun: Canada renews support to protect the world’s children against infectious diseases. Global Affairs Canada
• 25 Jun: Gavi Statment. Gavi
• 25 Jun: US to stop financial support of global vaccine alliance Gavi, health secretary. Reuters
• 25 Jun: Kennedy Withdraws U.S. Funding Pledge to International Vaccine Agency. The New York Times
• 25 Jun: Grand Challenges Canada to Anchor Gavi's Innovation Fund to Scale Immunization Solutions. The Globe & Mail
• 25 Jun: Price of first malaria vaccine to be slashed by more than half. Devex
• 25 Jun: Gavi pledges fall short about $2.9B as US pulls out. Devex
• 25 Jun: The Cruel Irony of Prevention. AVAC
• 25 Jun: Fostering better science by releasing biomedical research and innovation from the grip of rich nations. PLOS Global Public Health
• 25 Jun: Gavi statement on the global health architecture. Gavi
• 25 Jun: GAVI Vaccine Alliance Secures Whopping $9 Billion from Donors – Despite US Ambush at Pledging Event. Health Policy Watch
• 25 Jun: UK pledge to global vaccine effort falls £400m to £1.25bn amid raft of aid cuts. The Independent
• 25 Jun: NIH halts grant terminations ‘effective immediately,’ email says. STAT
• 25 Jun: Novel mRNA technology coaxes HIV out of hiding. POZ
• 25 Jun: CIDRZ administers first dose in groundbreaking shigella vaccine trial. Centre for Infectious Disease Research Zambia
• 25 Jun: Britain slashes global vaccine budget, putting millions of women and girls at risk. The Telegraph
• 25 Jun: World leaders recommit to immunisation amid global funding shortfall. Gavi
• 25 Jun: First all-oral treatment for deadly strain of sleeping sickness now available in Africa. Nature
• 26 Jun: ‘Single shot’ malaria vaccine delivery system could transform global immunisation. University of Oxford
• 26 Jun: Devex CheckUp: Gavi falls around $2.9 billion short. Devex
• 26 Jun: Spain's aid budget is rising — but has a long way to go. Devex
• 26 Jun: Tailored TB treatment based on disease severity may improve patient outcomes. MedicalXpress
• 26 Jun: Trial of Jynneos mpox vaccine begins in infants, toddlers, pregnant women. CIDRAP
• 26 Jun: New technology brings antibiotic resistance surveillance to the field. CIDRAP
• 26 Jun: Private sector, philanthropy can’t replace Trump administration science cuts. STAT
• 26 Jun: Gavi secures record number of pledges: now the hard work of immunising the world’s children begins. Gavi
• 26 Jun: Africa Unites to Take Stock of Disease Burden and Financial Needs towards NTDs Elimination by 2030. Africa CDC
• 27 Jun: How cuts to Gavi reflect US disengagement from development. Devex
• 27 Jun: CEPI appoints Executive Director of People and Organisation. CEPI
• 27 Jun: New credit card-sized TB test could close the diagnostic gap in HIV hotspots. MedicalXpress
• 27 Jun: The participation of people deprived of liberty in tuberculosis vaccine trials: should they be protected from research, or through research?. The Lancet
• 28 Jun: Lenacapavir approved for HIV but draws ire over cost. The Lancet
• 28 Jun: Luke O’Neill: New HIV jab raises hope of a world without Aids. The Irish Independent
• 30 Jun: Evaluating the impact of two decades of USAID interventions and projecting the effects of defunding on mortality up to 2030: a retrospective impact evaluation and forecasting analysis. The Lancet
• 30 Jun: Tracking maturity of the enabling environment for clinical trials. The Lancet
Upcoming Meetings/ Webinars
--------------------------